More Articles Back to Article
WHO names 3 Ebola vaccine candidates for Uganda trial
World Health Organization Director-General Tedros Adhanom Ghebreyesus revealed three Ebola vaccine candidates from Merck and the International AIDS Vaccine Initiative, the University of Oxford and Serum Institute of India, and the Sabin Vaccine Institute are expected to ship to Uganda for use in a planned clinical trial. All three vaccine candidates were evaluated by WHO's committee of external experts, who agreed on including these for testing in the trial. Reuters (11/16)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!